C-reactive protein in atherothrombosis and angiogenesis

L Badimon, E Peña, G Arderiu, T Padró… - Frontiers in …, 2018 - frontiersin.org
C-reactive protein (CRP) is a short pentraxin mainly found as a pentamer in the circulation,
or as non-soluble monomers CRP (mCRP) in tissues, exerting different functions. This …

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy

W Koenig - International journal of cardiology, 2013 - Elsevier
There is compelling experimental and clinical evidence suggesting a crucial role for
inflammation in the initiation and also the progression of atherosclerosis. Numerous …

Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction

A Abbate, CR Trankle, LF Buckley… - Journal of the …, 2020 - Am Heart Assoc
Background ST‐segment–elevation myocardial infarction is associated with an intense
acute inflammatory response and risk of heart failure. We tested whether interleukin‐1 …

C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection

BR Sahu, RK Kampa, A Padhi, AK Panda - Clinica chimica acta, 2020 - Elsevier
Background The novel coronavirus disease 2019 (COVID-19) first broke out in Wuhan,
China, spread over 227 countries and caused approximately 0.3 million death worldwide …

Effects of interleukin-1 blockade with anakinra on adverse cardiac remodeling and heart failure after acute myocardial infarction [from the Virginia Commonwealth …

A Abbate, BW Van Tassell, G Biondi-Zoccai… - The American journal of …, 2013 - Elsevier
A first pilot study of interleukin-1 blockade in ST-segment elevation acute myocardial
infarction showed improved remodeling. In the present second pilot study, we enrolled 30 …

Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra …

A Abbate, MC Kontos, JD Grizzard… - The American journal of …, 2010 - Elsevier
Acute myocardial infarction (AMI) initiates an intense inflammatory response in which
interleukin-1 (IL-1) plays a central role. The IL-1 receptor antagonist is a naturally occurring …

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical …

A Abbate, GF Wohlford, MG Del Buono… - European Heart …, 2022 - academic.oup.com
Aims ST-segment elevation myocardial infarction (STEMI) is associated with an intense
acute inflammatory response and an increased risk of death and heart failure (HF). In this …

Risk of mortality in COVID-19 patients: a meta-and network analysis

R Kowsar, AM Rahimi, M Sroka, A Mansouri… - Scientific reports, 2023 - nature.com
Understanding the most relevant hematological/biochemical characteristics, pre-existing
health conditions and complications in survivors and non-survivor will aid in predicting …

[HTML][HTML] The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease

DL Cozlea, DM Farcas, A Nagy… - Current health …, 2013 - ncbi.nlm.nih.gov
Introduction. Cardiovascular disease (CVD) is the major cause of premature death
worldwide. Hundreds of risk factors have been associated with cardiovascular disease …

Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction

G Vilahur, O Juan-Babot, E Peña, B Oñate… - Journal of molecular and …, 2011 - Elsevier
The extent of cardiac remodeling determines survival after acute MI. However, the
mechanisms driving cardiac remodeling remain unknown. We examined the effect of …